These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6336538)

  • 1. Theoretical study on conformation-related activity of hypoglycemic sulfonylureas.
    Brasseur R; Deleers M
    Pharmacol Res Commun; 1983 Nov; 15(10):901-7. PubMed ID: 6336538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of hypoglycemic sulfonylureas and negative phospholipids on calcium transport: ionic and conformational aspects.
    Deleers M; Grognet P; Mahy M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):407-24. PubMed ID: 6635329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranes.
    Deleers M; Brasseur R
    Pharmacol Res Commun; 1986 Feb; 18(2):129-36. PubMed ID: 3010341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of the hypoglycaemic sulphonylurea gliquidone. III. Conformational analysis.
    Lins L; Brasseur R; Malaisse WJ
    Pharmacol Res; 1996; 34(1-2):9-10. PubMed ID: 8981549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionophoretic activity of hypoglycemic sulfonylureas.
    Couturier E; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):323-34. PubMed ID: 6250506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids.
    Brown GR; Foubister AJ
    J Med Chem; 1984 Jan; 27(1):79-81. PubMed ID: 6361256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stoichiometry of calcium binding by hypoglycemic sulfonylureas.
    Deleers M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):181-201. PubMed ID: 6658185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionophoretic property of hypoglycemic sulfonylureas: competition between H+ and Ca2+.
    Deleers M; Couturier E; Mahy M; Gelbcke M; Malaisse WJ
    Ann Endocrinol (Paris); 1981; 42(3):297-9. PubMed ID: 7316466
    [No Abstract]   [Full Text] [Related]  

  • 9. Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family.
    Lins L; Brasseur R; Malaisse WJ
    Biochem Pharmacol; 1995 Nov; 50(11):1879-84. PubMed ID: 8615868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylureas.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2015 Jan; 65(1):101-4. PubMed ID: 25831689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of insulin secretion and its modulation by sulfonylureas.
    Panten U
    Contrib Nephrol; 1989; 73():16-21; discussion 22-3. PubMed ID: 2689091
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of hypoglycemic sulfonylureas on Ca2+ fluxes across lipid bilayers.
    Gylfe E; Hellman B; Arvidson G; Sandblom J
    Biochem Med; 1984 Apr; 31(2):246-53. PubMed ID: 6202299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effects of sulfonylureas (hypoglycemic agents) on the color reaction using oxidase].
    Sakoguchi T; Kitani Y; Kimura M; Hase A; Kobayashi K; Matsuoka A
    Rinsho Byori; 1982 May; 30(5):533-7. PubMed ID: 7131818
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfonylurea receptors and mechanism of sulfonylurea action.
    Panten U; Schwanstecher M; Schwanstecher C
    Exp Clin Endocrinol Diabetes; 1996; 104(1):1-9. PubMed ID: 8750563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of hypoglycemic sulfonylureas on catecholamine secretion and calcium uptake in cultured bovine adrenal chromaffin cells.
    Morita K; Nakanishi A; Murakumo Y; Oka M; Teraoka K
    Biochem Pharmacol; 1988 Mar; 37(5):983-5. PubMed ID: 3125840
    [No Abstract]   [Full Text] [Related]  

  • 19. A short series of antidiabetic sulfonylureas exhibit multiple ligand PPARgamma-binding patterns.
    Arrault A; Rocchi S; Picard F; Maurois P; Pirotte B; Vamecq J
    Biomed Pharmacother; 2009 Jan; 63(1):56-62. PubMed ID: 18280694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of hypoglycemic sulfonylureas. IV. Interference of sulfonylureas with mitochondrial oxidative phosphorylation.
    Mannaerts G; Debeer L; Ceuterick-Goethals AM; De Schepper PJ
    Biochem Pharmacol; 1974 Jan; 23(2):239-50. PubMed ID: 4205027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.